By Counterforce Health Team in Keytruda (pembrolizumab) —

How to Get Keytruda (Pembrolizumab) Covered by Cigna in Texas: Appeals Guide with Forms and Timelines

Quick Answer: Getting Keytruda Covered by Cigna in Texas

Keytruda (pembrolizumab) requires prior authorization from Cigna and is dispensed through Accredo specialty pharmacy. Submit biomarker documentation (PD-L1, MSI-H, or TMB-H results), complete diagnosis staging, and prior therapy records via CoverMyMeds portal or fax. If denied, you have 180 days to file an internal appeal with Cigna, followed by external review through Texas Department of Insurance if medical necessity is disputed. First step today: Call Cigna member services (number on your insurance card) to confirm PA requirements and request the oncology precertification form.

Table of Contents

  1. Read Your Denial Letter
  2. Common Fixable Issues
  3. First-Level Appeal Strategy
  4. Peer-to-Peer Review Process
  5. External Review in Texas
  6. Appeal Templates and Scripts
  7. Coverage Requirements at a Glance
  8. Costs and Financial Assistance
  9. When to Escalate
  10. Frequently Asked Questions

Read Your Denial Letter

When Cigna denies Keytruda coverage, your denial letter contains crucial information for building your appeal. Look for these key elements:

Denial Reason Codes

  • Medical necessity: Cigna believes the treatment isn't appropriate for your condition
  • Non-formulary: Keytruda isn't on your plan's preferred drug list
  • Step therapy: You must try other treatments first
  • Quantity limits: Dosing exceeds plan parameters
  • Missing documentation: Biomarker results or staging information incomplete

Critical Deadlines Your denial letter will specify appeal deadlines. For Cigna plans in Texas, you typically have:

  • 180 days to file internal appeals from the denial date
  • 65 days for Medicare Advantage appeals
  • 24-72 hours for expedited appeals in urgent situations
Tip: Take a photo of your denial letter immediately and note the deadline on your calendar. Missing these deadlines can forfeit your appeal rights.

Common Fixable Issues

Many Keytruda denials stem from incomplete submissions rather than true medical necessity disputes. Here's how to address the most common problems:

Missing Biomarker Documentation

The Issue: Cigna requires specific biomarker testing results depending on your cancer type.

The Fix: Ensure your oncologist submits:

  • PD-L1 Combined Positive Score (CPS) for melanoma, lung cancer, and head/neck cancers
  • MSI-H (Microsatellite Instability-High) confirmation via NGS or IHC testing
  • TMB-H (Tumor Mutational Burden-High) results showing ≥10 mutations/megabase
  • dMMR (Mismatch Repair Deficiency) testing as alternative to MSI-H

Incomplete Prior Therapy Records

The Issue: Step therapy requirements aren't clearly documented.

The Fix: Your physician should provide detailed records showing:

  • Specific medications tried (drug names, doses, duration)
  • Treatment failure documentation (progression scans, lab results)
  • Intolerance or contraindication notes
  • Dates of treatment attempts

Coding Mismatches

The Issue: Diagnosis codes don't align with FDA-approved indications.

The Fix: Verify your medical records include correct ICD-10 codes and TNM/AJCC staging that match Keytruda's labeled indications.

First-Level Appeal Strategy

A successful Keytruda appeal requires systematic documentation that addresses Cigna's specific denial reasons. Here's your action plan:

Medical Necessity Letter Components

Your oncologist should include these elements in the appeal letter:

Patient Information

  • Full name, date of birth, and Cigna policy/member ID
  • Complete cancer diagnosis with ICD-10 codes
  • TNM staging and disease progression timeline

Clinical Rationale

  • FDA-approved indication confirmation
  • NCCN guideline references (category 1 or 2A recommendations)
  • Biomarker results supporting Keytruda use
  • Prior treatment failures with specific dates and outcomes

Treatment Plan

  • Proposed dosing schedule (200mg every 3 weeks or 400mg every 6 weeks)
  • Expected treatment duration
  • Monitoring plan and safety protocols

Required Supporting Documents

Attach these materials to strengthen your appeal:

  • Complete pathology reports with biomarker results
  • Imaging studies showing disease progression
  • Laboratory results (complete blood count, liver function, thyroid function)
  • Prior therapy summary with failure documentation
  • ECOG performance status assessment
Note: Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with payer-specific requirements.

Peer-to-Peer Review Process

Requesting a peer-to-peer review can significantly improve your appeal success rate. Cigna Medicare Advantage plans have an 85.3% appeal overturn rate overall, with peer-to-peer reviews achieving 80%+ success rates.

How to Request

Your oncologist should:

  1. Call Cigna's provider services line (found on your insurance card)
  2. Request a peer-to-peer review with a Cigna medical director
  3. Schedule the call within 5-7 business days of the appeal submission

Preparation Checklist for Your Doctor

Key Talking Points:

  • Specific NCCN guideline category supporting Keytruda use
  • Patient's biomarker profile and why it predicts response
  • Prior therapy failures and contraindications to alternatives
  • Clinical urgency if treatment delay poses risks

Documentation Ready:

  • Patient's complete medical record
  • Biomarker test results
  • Imaging showing disease progression
  • Treatment history timeline

External Review in Texas

If Cigna upholds their denial after internal appeals, Texas law provides access to independent external review for medical necessity disputes.

Eligibility Requirements

You can request external review if:

  • You've completed Cigna's internal appeal process
  • The denial is based on medical necessity, appropriateness, or experimental/investigational status
  • You file within 4 months of Cigna's final denial

How to Request External Review

  1. Use the form provided with Cigna's final denial letter
  2. Submit to Cigna (not directly to the Texas Department of Insurance)
  3. Include new supporting evidence if available
  4. Request expedited review if treatment delay poses health risks

Timeline and Process

  • Standard review: 20 days maximum
  • Expedited review: 3 business days for urgent cases
  • Cost: Free to you (Cigna pays the Independent Review Organization)
  • Decision: Binding on Cigna if overturned

For questions about the external review process, contact the Texas Department of Insurance at 1-800-252-3439 or visit tdi.texas.gov.

Appeal Templates and Scripts

Patient Phone Script for Cigna

"Hi, I'm calling about a prior authorization denial for Keytruda. My member ID is [ID number]. I'd like to understand the specific denial reasons and request information about filing an appeal. Can you also provide the fax number and forms needed for my oncologist to submit additional clinical documentation?"

Medical Necessity Letter Template

[Physician Letterhead]
[Date]

Re: [Patient Name], DOB: [Date], Member ID: [ID]
Diagnosis: [Specific cancer type with ICD-10 code]

Dear Cigna Medical Review Team:

I am requesting reconsideration for Keytruda (pembrolizumab) coverage for my patient diagnosed with [specific indication]. This treatment meets medical necessity criteria based on:

1. **FDA Approval**: Keytruda is FDA-approved for [specific indication]
2. **NCCN Guidelines**: Category [1 or 2A] recommendation for this clinical scenario
3. **Patient-Specific Factors**: [Biomarker results, prior failures, contraindications]
4. **Clinical Evidence**: [Reference key studies supporting use]

Attached documentation includes pathology reports, biomarker results, and prior treatment records demonstrating medical necessity.

Sincerely,
[Physician name and credentials]

Coverage Requirements at a Glance

Requirement Details Source
Prior Authorization Required for all Keytruda prescriptions Cigna precertification list
Specialty Pharmacy Dispensed through Accredo Express Scripts network
Biomarker Testing PD-L1, MSI-H, or TMB-H as indication-specific Cigna oncology policy
Step Therapy May require prior treatments depending on indication Plan-specific formulary
Site of Care Typically covered in outpatient infusion centers Medical benefit
Appeals Deadline 180 days from denial (65 days for Medicare Advantage) Texas Insurance Code

Costs and Financial Assistance

Keytruda costs approximately $23,591 per 6-week dose, making financial assistance crucial for most patients.

Manufacturer Support

Merck Access Program:

  • Copay assistance up to $25,000 annually for commercially insured patients
  • Patient assistance program for uninsured/underinsured patients
  • Eligibility screening available at merckhelps.com

Additional Resources

  • CancerCare Copay Assistance: Up to $15,000 annually for eligible patients
  • HealthWell Foundation: Cancer-specific grants based on financial need
  • Patient Advocate Foundation: Copay relief and insurance appeals assistance
From our advocates: "We've seen patients successfully combine manufacturer copay cards with foundation grants to reduce out-of-pocket costs from thousands to under $100 per treatment. The key is applying to multiple programs simultaneously since award decisions can take 2-4 weeks."

When to Escalate

If your appeals aren't successful through normal channels, consider these escalation options:

Texas Department of Insurance Complaint

File a complaint if you believe Cigna:

  • Violated Texas insurance laws
  • Failed to follow proper appeal procedures
  • Made decisions not based on medical evidence

Contact: 1-800-252-3439 or tdi.texas.gov/consumer/complaint-health.html

Office of Public Insurance Counsel

OPIC provides free consumer advocacy for insurance disputes: Phone: 1-877-611-6742 Services: Appeal guidance, complaint assistance, and consumer education

Congressional Representative

Contact your U.S. Representative's office for assistance with insurance disputes, especially if multiple appeals have failed. Congressional inquiries often prompt faster insurer responses.

Frequently Asked Questions

How long does Cigna prior authorization take in Texas? Standard review takes 2-5 business days. Expedited review for urgent cases takes 24-72 hours. Submit through CoverMyMeds portal for fastest processing.

What if Keytruda is non-formulary on my Cigna plan? Request a formulary exception by having your oncologist document that preferred alternatives are contraindicated, ineffective, or medically inappropriate for your specific case.

Can I get expedited appeals in Texas? Yes, if treatment delay would jeopardize your health. Request expedited review when filing your appeal and provide documentation of clinical urgency.

Does step therapy apply if I failed treatments in another state? Yes, documented treatment failures from other states count toward step therapy requirements. Ensure your physician includes complete treatment records.

What happens if external review denies coverage? External review decisions are binding, but you may have options through manufacturer patient assistance programs, clinical trials, or alternative treatments covered by your plan.

How can I track my appeal status? Log into your Cigna member portal online or call member services. Keep detailed records of all communications, including reference numbers and representative names.

Do I need a lawyer for insurance appeals? Most successful appeals don't require legal representation. However, consider consulting an attorney specializing in insurance law if multiple appeals fail or if you suspect bad faith denial practices.

Can I continue current treatment during appeals? If you're already receiving Keytruda, some plans provide continuation of care during appeals. Request this explicitly when filing your appeal to avoid treatment interruption.

At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by providing evidence-backed rebuttals aligned with each payer's specific requirements. Our platform analyzes denial letters and plan policies to identify the exact documentation needed for approval.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on your specific plan terms and clinical circumstances. Always consult with your healthcare provider and insurance company for personalized guidance. For additional help with insurance appeals in Texas, contact the Texas Department of Insurance consumer hotline at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.